The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up

Brain

Volumn 121, Issue 3, 1998, Pages 495-503

  O'Riordan, J I ^a   Thompson, A J ^a   Kingsley, D P E ^a   MacManus, D G ^a   Kendall, B E ^a   Rudge, P ^a   McDonald, W I ^a,b   Miller, D H ^a,c  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Clinically isolated syndromes; Multiple sclerosis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRAIN STEM; CHILD; DEMYELINATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; REMISSION; SPINAL CORD;

ADOLESCENT; ADULT; BRAIN; CENTRAL NERVOUS SYSTEM DISEASES; COHORT STUDIES; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SYNDROME;

EID: 0031882301     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/121.3.495     Document Type: Article

References (47)

1. Atlas SW, Grossman RI, Goldberg HI, Hackney DB, Bilaniuk LT, Zimmerman RA. MR diagnosis of acute disseminated encephalomyelitis. J Comput Assist Tomogr 1986; 10: 798-801.
2. Barkhof F, Filippi M, Miller DH, Scheltens P, Campi A, Polman C, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120: 2059-69.
3. Beck RW, Cleary PA, Trobe JD, Kaufman DI, Kupersmith MJ, Paty DW, et al. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis [see comments]. N Eng J Med 1993; 329: 1764-9. Comment in: N Eng J Med 1993; 329: 1808-10. Comment in: N Eng J Med 1993; 330: 1238-9. Comment in: ACPJ Club 1994; 120 Suppl 3: 61.
4. Bradley WG, Whitty CW. Acute optic neuritis: prognosis for development of multiple sclerosis. J Neurol Neurosurg Psychiatry 1968; 31: 10-8.
5. Campi A, Filippi M, Comi G, Martinelli V, Baratti C, Rovaris M, et al. Acute transverse myelopathy: spinal and cranial MR study with clinical follow-up. AJNR Am J Neuroradiol 1995; 16: 115-23.
6. Cohen MM, Lessell S, Wolf PA. A prospective study of the risk of developing multiple sclerosis in uncomplicated optic neuritis. Neurology 1979; 29: 208-13.
7. Compston DA, Batchelor JR, Earl CJ, McDonald WI. Factors influencing the risk of multiple sclerosis developing in patients with optic neuritis. Brain 1978; 101: 495-511.
8. Davie CA, Barker GJ, Webb S, Tofts PS, Thompson AJ, Harding AE, et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss [published erratum appears in Brain 1996; 119: 1415]. Brain 1995; 118: 1583-92.
9. Engell T. A clinical patho-anatomical study of clinically silent multiple sclerosis [see comments]. Acta Neurol Scand 1989; 79: 428-30. Comment in: Acta Neurol Scand 1990; 81: 363.
10. Filippi M, Horsfield MA, Morrissey SP, MacManus DG, Rudge P, McDonald WI, et al. Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology 1994; 44: 635-41.
11. Ford B, Tampieri D, Francis G. Long-term follow-up of acute partial transverse myelopathy [see comments]. Neurology 1992; 42: 250-2. Comment in: Neurology 1992; 42: 2057.
12. Francis DA, Compston DA, Batchelor JR, McDondald WI. A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up. J Neurol Neurosurg Psychiatry 1987; 50: 758-65.
13. Frederiksen JL, Larsson HB, Olesen J, Stigsby B. MRI, VEP, SEP and biothesiometry suggest monosymptomatic acute optic neuritis to be a first manifestation of multiple sclerosis. Acta Neurol Scand 1991; 83: 343-50.
14. Gilbert JJ, Sadler M. Unsuspected multiple sclerosis. Arch Neurol 1983; 40: 533-6.
15. Isaac C, Li DK, Genton M, Jardine C, Grochowski E, Palmer M, et al. Multiple sclerosis: a serial study using MRI in relapsing patients. Neurology 1988; 38: 1511-5.
16. Jacobs L, Munschauer FE, Kaba SE. Clinical and magnetic resonance imaging in optic neuritis. Neurology 1991; 41: 15-9.
17. Jacobs LD, Cookfair DL, Rudick RA, Herndon RM, Richert JR, Salazar AM, et al. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis [see comments]. Ann Neurol 1996; 39: 285-94. Comment in: ACPJ Club 1996; 125: 35. Comment in: Ann Neurol 1996; 40: 951-3. Comment in: Ann Neurol 1997; 41: 560.
18. Jacobs LD, Kaba SE, Miller CM, Priore RL, Brownscheidle CM. Correlation of clinical, magnetic resonance imaging, and CSF findings in optic neuritis. Ann Neurol 1997; 41: 392-8.
19. Kesselring J, Miller DH, Robb SA, Kendall BE, Moseley IF, Kingsley D, et al. Acute disseminated encephalomyelitis: MRI findings and the distinction from multiple sclerosis. Brain 1990; 113: 291-302.
20. Kidd D, Thorpe JW, Thompson AJ, Kendall BE, Moseley IF, MacManus DG, et al. Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 1993; 43: 2632-7.
21. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
22. Landy PJ. A prospective study of the risk of developing multiple sclerosis in optic neuritis in a tropical and sub-tropical area. J Neurol Neurosurg Psychiatry 1983; 46: 659-61.
23. Lee KH, Hashimoto SA, Hooge JP, Kastrukoff LF, Oger JJ, Li DK, et al. Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 1991; 41: 657-60.
24. Lipton HL, Teasdall RD. Acute transverse myelopathy in adults. Arch Neurol 1973; 28: 252-7.
25. Losseff NA, Wang L, Lai HM, Yoo DS, Gawne-Cain ML, McDonald WI, et al. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. Brain 1996a; 119: 2009-19.
26. Losseff NA, Webb SL, O'Riordan JI, Page R, Wang L, Barker GJ, et al. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 1996b; 119: 701-8.
27. McFarland HF, Frank JA, Albert PS, Smith ME, Martin R, Harris JO, et al. Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol 1992; 32: 758-66.
28. Martinelli V, Comi G, Filippi M, Poggi A, Colombo B, Rodegher M, et al. Paraclinical tests in acute-onset optic neuritis: basal data and results of a short follow-up. Acta Neurol Scand 1991; 84: 231-6.
29. Miller, DH, McDonald WI, Blumhardt LD, du Boulay GH, Halliday AM, Johnson G, et al. Magnetic resonance imaging in isolated noncompressive spinal cord syndromes. Ann Neurol 1987; 22: 714-23.
30. Miller DH, Ormerod IE, McDonald WI, MacManus DG, Kendall BE, Kingsley DPE, et al. The early risk of multiple sclerosis after optic neuritis. J Neurol Neurosurg Psychiatry 1988; 51: 1569-71.
31. Miller DH, Ormerod IE, Rudge P, Kendall BE, Moseley IF, McDonald WI. The early risk of multiple sclerosis following isolated acute syndromes of the brainstem and spinal cord. Ann Neurol 1989; 26: 635-9.
32. Miller DH, Albert PS, Barkhof F, Francis G, Frank JA, Hodgkinson S, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 1996; 39: 6-16.
33. Morrissey SP, Miller DH, Kendall BE, Kingsley DP, Kelly MA, Francis DA, et al. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Brain 1993; 116: 135-46.
34. O'Riordan JI, Losseff N, Thompson AJ, Miller DH. Asymptomatic spinal cord lesions in clinically isolated optic neuritis or brain stem syndromes [abstract]. J Neurol 1996; 243 Suppl 2: 18.
35. Ormerod IE, McDonald WI, du Boulay GH, Kendall BE, Moseley IF, Halliday AM, et al. Disseminated lesions at presentation in patients with optic neuritis. J Neurol Neurosurg Psychiatry 1986a; 49: 124-7.
36. Ormerod IE, Bronstein A, Rudge P, Johnson G, MacManus D, Halliday AM, et al. Magnetic resonance imaging in clinically isolated lesions of the brain stem. J Neurol Neurosurg Psychiatry 1986b; 49: 737-43.
37. Paty DW, Oger JJ, Kastrukoff LF, Hashimoto SA, Hooge JP, Eisen AA, et al. MRI in the diagnosis of MS. A prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 1988; 38: 180-5.
38. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
39. Rizzo JF 3d, Lessell S. Risk of developing multiple sclerosis after uncomplicated optic neuritis: a long-term prospective study. Neurology 1988; 38: 185-90.
40. Sandberg-Wollheim M, Bynke H, Cronqvist S, Holtas S, Platz P, Ryder LP. A long-term prospective study of optic neuritis: evaluation of risk factors. Ann Neurol 1990; 27: 386-93.
41. Sharief MK, Thompson EJ. The predictive value of intrathecal immunoglobulin synthesis and magnetic resonance imaging in acute isolated syndromes for subsequent development of multiple sclerosis. Ann Neurol 1991; 29: 147-51.
42. Soderstrom M, Lindqvist M, Hillert J, Kall T-B, Link H. Optic neuritis: findings on MRI, CSF examination and HLA class II typing in 60 patients and results of short term follow up. J Neurol 1994; 241: 391-7.
43. Tas MW, Barkhof F, van Walderveen MA, Polman CH, Hommes OR, Valk J. The effects of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis. Am J Neuroradiol 1995; 16: 259-64.
44. IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebocontrolled trial [see comments]. Neurology 1993; 43: 655-61. Comment in: Neurology 1993; 43: 641-3.
45. IFNB Multiple Sclerosis Study Group, University of British Columbia MS/MRI Analysis Group. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized, controlled trial [see comments]. Neurology 1995; 45: 1277-85. Comment in: ACPJ Club 1996; 124: 3. Comment in: Neurology 1996; 47: 1110-2.
46. Thompson AJ, Miller D, Youl B, MacManus D, Moore S, Kingsley D, et al. Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration. Neurology 1992; 42: 60-3.
47. 1-weighted) spin-echo images. Neurology 1995; 45: 1684-90.